Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Inventory (2022 - 2026)

HeartSciences' Inventory history spans 5 years, with the latest figure at $657285.0 for Q1 2026.

  • For Q1 2026, Inventory rose 0.79% year-over-year to $657285.0; the TTM value through Jan 2026 reached $657285.0, up 0.79%, while the annual FY2025 figure was $650267.0, 3.35% up from the prior year.
  • Inventory reached $657285.0 in Q1 2026 per HSCS's latest filing, roughly flat from $657285.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $677669.0 in Q3 2022 to a low of $629179.0 in Q2 2024.
  • Average Inventory over 5 years is $662239.8, with a median of $663781.5 recorded in 2024.
  • Peak YoY movement for Inventory: decreased 6.98% in 2024, then rose 3.35% in 2025.
  • A 5-year view of Inventory shows it stood at $677669.0 in 2022, then fell by 0.42% to $674839.0 in 2023, then decreased by 3.25% to $652907.0 in 2024, then rose by 0.67% to $657285.0 in 2025, then changed by 0.0% to $657285.0 in 2026.
  • Per Business Quant, the three most recent readings for HSCS's Inventory are $657285.0 (Q1 2026), $657285.0 (Q4 2025), and $649507.0 (Q3 2025).